Vital Farms (NASDAQ:VITL - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a "hold" rating to a "strong sell" rating in a research note issued on Saturday.
VITL has been the subject of several other research reports. Telsey Advisory Group lowered shares of Vital Farms from an "outperform" rating to a "market perform" rating and set a $11.00 price target for the company. in a research report on Friday. Craig Hallum lowered shares of Vital Farms from a "buy" rating to a "hold" rating and set a $10.00 price target for the company. in a research report on Friday. DA Davidson reaffirmed a "neutral" rating and set a $16.00 price target (down from $47.00) on shares of Vital Farms in a research report on Monday, May 4th. Morgan Stanley set a $10.00 price target on shares of Vital Farms in a research report on Friday. Finally, Stifel Nicolaus reaffirmed a "hold" rating and set a $10.00 price target (down from $34.00) on shares of Vital Farms in a research report on Friday. Five research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, Vital Farms has an average rating of "Hold" and an average price target of $27.92.
View Our Latest Research Report on VITL
Vital Farms Price Performance
Shares of NASDAQ:VITL opened at $8.94 on Friday. Vital Farms has a fifty-two week low of $8.40 and a fifty-two week high of $53.13. The business has a 50-day simple moving average of $14.91 and a two-hundred day simple moving average of $25.49. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.61 and a current ratio of 1.77. The firm has a market cap of $383.08 million, a price-to-earnings ratio of 8.60 and a beta of 1.20.
Vital Farms (NASDAQ:VITL - Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by ($0.12). Vital Farms had a return on equity of 14.47% and a net margin of 6.10%.The business had revenue of $187.16 million during the quarter, compared to analysts' expectations of $182.40 million. During the same period last year, the firm posted $0.37 EPS. Vital Farms's quarterly revenue was up 15.4% compared to the same quarter last year. On average, analysts expect that Vital Farms will post 0.86 earnings per share for the current year.
Insider Activity
In related news, major shareholder Matthew Ohayer sold 20,000 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $20.33, for a total value of $406,600.00. Following the completion of the sale, the insider directly owned 6,321,190 shares of the company's stock, valued at approximately $128,509,792.70. This represents a 0.32% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Karl Khoury bought 5,000 shares of Vital Farms stock in a transaction that occurred on Monday, March 9th. The stock was purchased at an average cost of $18.45 per share, with a total value of $92,250.00. Following the completion of the acquisition, the director directly owned 119,789 shares in the company, valued at $2,210,107.05. This represents a 4.36% increase in their position. The SEC filing for this purchase provides additional information. 21.30% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Vital Farms
Several hedge funds and other institutional investors have recently added to or reduced their stakes in VITL. Royal Bank of Canada increased its holdings in Vital Farms by 89.2% in the 1st quarter. Royal Bank of Canada now owns 19,381 shares of the company's stock worth $591,000 after acquiring an additional 9,136 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Vital Farms by 5.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,057 shares of the company's stock worth $611,000 after acquiring an additional 1,108 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in Vital Farms by 3.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 415,420 shares of the company's stock worth $12,658,000 after acquiring an additional 13,397 shares in the last quarter. Woodline Partners LP purchased a new stake in Vital Farms in the 1st quarter worth approximately $1,073,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Vital Farms by 1.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 89,893 shares of the company's stock worth $2,739,000 after acquiring an additional 1,198 shares in the last quarter. 98.59% of the stock is owned by hedge funds and other institutional investors.
Vital Farms News Roundup
Here are the key news stories impacting Vital Farms this week:
- Positive Sentiment: Vital Farms still posted revenue above estimates for the quarter, with sales rising 15.4% year over year, which suggests demand for its premium egg products remains intact. Vital Farms earnings report
- Neutral Sentiment: William Blair reaffirmed its market perform rating on Vital Farms, indicating the firm is not turning more bearish even after the selloff. William Blair rating note
- Neutral Sentiment: Several law firms issued reminders about the pending securities class action and May 26 lead-plaintiff deadline, keeping investor attention on litigation risk. Rosen Law Firm notice
- Neutral Sentiment: Faruqi & Faruqi, The Gross Law Firm, Schall, Robbins, Pomerantz, Berger Montague and others also reiterated class-action notices, adding to the overhang but not changing the underlying fundamentals by themselves. Class action lawsuit notice
- Negative Sentiment: Craig Hallum downgraded Vital Farms from buy to hold, signaling less enthusiasm after the disappointing quarter and weaker outlook. Craig Hallum downgrade
- Negative Sentiment: The main driver of the stock weakness was the earnings miss and sharply reduced FY2026 revenue guidance of $775 million to $800 million, which fell well below the market's expectations and raised concerns about margin pressure and slower growth. Earnings and guidance article
Vital Farms Company Profile
(
Get Free Report)
Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms' supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.
Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.